PL345365A1 - Salts of paroxetine - Google Patents

Salts of paroxetine

Info

Publication number: PL345365A1
Authority: PL; Poland
Prior art keywords: paroxetine; salts
Prior art date: 1998-07-02

Application number

PL99345365A

Other languages

English (en)

Inventor

Victor Witold Jacewicz

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-02

Filing date

1999-06-30

Publication date

2001-12-17

1999-06-30 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2001-12-17 Publication of PL345365A1 publication Critical patent/PL345365A1/xx

Links

AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical class C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 1
229960002296 paroxetine Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyridine Compounds (AREA)

PL99345365A 1998-07-02 1999-06-30 Salts of paroxetine PL345365A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9814316.7A GB9814316D0 (en)	1998-07-02	1998-07-02	Novel compounds
PCT/EP1999/004543 WO2000001692A1 (en)	1998-07-02	1999-06-30	Salts of paroxetine

Publications (1)

Publication Number	Publication Date
PL345365A1 true PL345365A1 (en)	2001-12-17

Family

ID=10834803

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL99345365A PL345365A1 (en)	1998-07-02	1999-06-30	Salts of paroxetine

Country Status (21)

Country	Link
EP (1)	EP1091958A1 (no)
JP (1)	JP2002519421A (no)
KR (1)	KR20010053337A (no)
CN (1)	CN1314906A (no)
AP (1)	AP2000002017A0 (no)
AU (2)	AU4903999A (no)
BG (1)	BG105204A (no)
BR (1)	BR9911679A (no)
CA (1)	CA2336470A1 (no)
CZ (1)	CZ20004923A3 (no)
EA (1)	EA200100098A1 (no)
GB (1)	GB9814316D0 (no)
HU (1)	HUP0103712A3 (no)
ID (1)	ID27766A (no)
IL (1)	IL140385A0 (no)
NO (1)	NO20006547L (no)
PL (1)	PL345365A1 (no)
SK (1)	SK20242000A3 (no)
TR (1)	TR200100055T2 (no)
WO (1)	WO2000001692A1 (no)
ZA (2)	ZA992899B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI1622630T1 (sl)	2003-05-07	2012-12-31	Osteologix A/S	Stroncijeva kombinacije za profilakso/zdravljenje patologij hrustanca in/ali kosti
ES2275218T3 (es)	2003-05-07	2007-06-01	Osteologix A/S	Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
KR101165614B1 (ko)	2004-02-26	2012-07-18	오스테올로지스 에이에스	괴사성 골 질환의 예방 또는 치료에 사용하기 위한스트론튬 함유 화합물
US7589235B2 (en)	2004-05-06	2009-09-15	Osteologix, A/S	High yield and rapid synthesis methods for producing metallo-organic salts
KR100672184B1 (ko)	2004-09-21	2007-01-19	주식회사종근당	파록세틴의 콜린산 또는 콜린산 유도체 염
JP2010504281A (ja) *	2006-07-27	2010-02-12	エミスフェアー・テクノロジーズ・インク	アリールスルファニル化合物、および活性薬剤を送達するための組成物
CN109212055B (zh) *	2018-08-19	2021-05-07	丁立平	一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法
CN109342633B (zh) *	2018-11-27	2020-10-02	北京市化工职业病防治院	尿液中苯、甲苯和二甲苯代谢物的检测方法
CN111337460B (zh) *	2018-12-18	2021-09-17	中国科学院大连化学物理研究所	一种高稳定性Halo-tag探针及其合成和生物应用
CN116283778B (zh) *	2023-02-23	2025-08-29	江苏理工学院	一种吡唑羧酸类化合物及其制备方法和应用
US20250091996A1 (en)	2023-09-15	2025-03-20	King Faisal University	2-(1h-imidazole-1-carbonyl)benzoic acid as an anticancer compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8430581D0 (en) *	1984-12-04	1985-01-09	Ferrosan As	Treatment
EP0223403B1 (en) *	1985-10-25	1993-08-04	Beecham Group Plc	Piperidine derivative, its preparation, and its use as medicament
CA2206592A1 (en) *	1996-05-30	1997-11-30	Shu-Zhong Wang	Method of producing amorphous paroxetine hydrochloride
HU221921B1 (hu) *	1996-07-08	2003-02-28	Richter Gedeon Vegyészeti Gyár Rt.	N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
EE03970B1 (et) *	1997-06-10	2003-02-17	Synthon B.V.	4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim
CA2319652A1 (en) *	1998-02-06	1999-08-12	Michael Urquhart	Salts of paroxetine

1998
- 1998-07-02 GB GBGB9814316.7A patent/GB9814316D0/en not_active Ceased
1999
- 1999-04-23 ZA ZA9902899A patent/ZA992899B/xx unknown
- 1999-06-30 EA EA200100098A patent/EA200100098A1/ru unknown
- 1999-06-30 IL IL14038599A patent/IL140385A0/xx unknown
- 1999-06-30 CN CN99810197A patent/CN1314906A/zh active Pending
- 1999-06-30 AP APAP/P/2000/002017A patent/AP2000002017A0/en unknown
- 1999-06-30 CA CA002336470A patent/CA2336470A1/en not_active Abandoned
- 1999-06-30 ID IDW20010252A patent/ID27766A/id unknown
- 1999-06-30 JP JP2000558095A patent/JP2002519421A/ja active Pending
- 1999-06-30 AU AU49039/99A patent/AU4903999A/en not_active Abandoned
- 1999-06-30 WO PCT/EP1999/004543 patent/WO2000001692A1/en not_active Ceased
- 1999-06-30 BR BR9911679-0A patent/BR9911679A/pt not_active Application Discontinuation
- 1999-06-30 TR TR2001/00055T patent/TR200100055T2/xx unknown
- 1999-06-30 PL PL99345365A patent/PL345365A1/xx not_active Application Discontinuation
- 1999-06-30 EP EP99932772A patent/EP1091958A1/en not_active Withdrawn
- 1999-06-30 KR KR1020007015100A patent/KR20010053337A/ko not_active Withdrawn
- 1999-06-30 SK SK2024-2000A patent/SK20242000A3/sk unknown
- 1999-06-30 CZ CZ20004923A patent/CZ20004923A3/cs unknown
- 1999-06-30 HU HU0103712A patent/HUP0103712A3/hu unknown
2000
- 2000-12-21 NO NO20006547A patent/NO20006547L/no not_active Application Discontinuation
2001
- 2001-01-02 ZA ZA200100020A patent/ZA200100020B/en unknown
- 2001-01-31 BG BG105204A patent/BG105204A/xx unknown
- 2001-07-11 AU AU2002100370A patent/AU2002100370A4/en not_active Expired

Also Published As

Publication number	Publication date
GB9814316D0 (en)	1998-09-02
ZA992899B (en)	2000-03-29
JP2002519421A (ja)	2002-07-02
AP2000002017A0 (en)	2000-12-31
CZ20004923A3 (cs)	2001-08-15
HUP0103712A3 (en)	2002-09-30
SK20242000A3 (sk)	2001-07-10
IL140385A0 (en)	2002-02-10
AU2002100370A4 (en)	2002-06-06
NO20006547D0 (no)	2000-12-21
WO2000001692A1 (en)	2000-01-13
EP1091958A1 (en)	2001-04-18
NO20006547L (no)	2001-02-12
HUP0103712A2 (hu)	2002-05-29
AU4903999A (en)	2000-01-24
BR9911679A (pt)	2002-01-29
BG105204A (en)	2001-11-30
CN1314906A (zh)	2001-09-26
TR200100055T2 (tr)	2001-07-23
ZA200100020B (en)	2002-03-25
KR20010053337A (ko)	2001-06-25
CA2336470A1 (en)	2000-01-13
ID27766A (id)	2001-04-26
EA200100098A1 (ru)	2001-08-27

Legal Events

Date	Code	Title	Description
2007-07-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
GB2336364B (en)	2000-05-10	Paroxetine salt
IL137616A0 (en)	2001-07-24	Variants of vegf-a
PL346544A1 (en)	2002-02-11	Crystalline forms of eto2
IL140385A0 (en)	2002-02-10	Salts of paroxetine
IL137684A0 (en)	2001-10-31	Salts of paroxetine
PL345999A1 (en)	2002-01-14	Crystalline forms of osanetant
AU1788800A (en)	2000-07-03	Derivative of paroxetine
IL140766A0 (en)	2002-02-10	Novel salts of n-tert-butylhydroxylamine
PL343095A1 (en)	2001-07-30	Paroxetine compositions
IL138920A0 (en)	2001-11-25	Paroxetine maleate
IL144444A0 (en)	2002-05-23	New morpholinobenzamide salts
IL139596A0 (en)	2002-02-10	Novel formulation containing paroxetine
HUP0101215A3 (en)	2002-05-28	Chrystalline form of paroxetine
IL139081A0 (en)	2001-11-25	Paroxetine ascorbate
PL344573A1 (en)	2001-11-05	Novel formulation containing paroxetine
HK1035900A (en)	2001-12-14	Salts of paroxetine
HK1034066A (en)	2001-10-12	Salts of paroxetine
HU9904011D0 (en)	2000-01-28	Novel salts of dipeptid derivatives
AU1398300A (en)	2000-06-19	Amine salts of paroxetine
AU5294899A (en)	2000-02-28	Paroxetine salts
SI1102747T1 (en)	2004-02-29	Crystalline forms of osanetant
PL340294A1 (en)	2001-01-29	Antipsychoic substituted derivatives of piperidine
HK1034072A (en)	2001-10-12	Crystalline form of paroxetine
TW392709U (en)	2000-06-01	Structure of color-testing machine
TW354479U (en)	1999-03-11	Improvement of earpick